RAPP · Rapport Therapeutics, Inc.

$40.94 -1.02 (-2.43%) At close · Jul 29

Market Cap

$1.96B

47.83M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Abraham N. Ceesay	CEO	$652,927	—	—	$5,156,416	$431,059	$24,772	$6,265,174
Jeffrey Sevigny	Chief Medical Officer	$561,087	—	—	$2,101,230	$283,780	$77,845	$3,023,942
Troy Ignelzi	CFO	$519,846	—	—	$1,710,773	$249,600	$25,920	$2,506,139

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Abraham N. Ceesay	CEO	$576,538	—	—	$8,947,874	$293,590	$21,155	$9,839,157
Troy Ignelzi	CFO	$468,462	—	—	$1,788,835	$170,000	$37,074	$2,464,371
Bradley Galer	Former Chief Medical Officer	$466,885	$75,000	—	$1,707,981	$163,200	$18,408	$2,431,474

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Abraham N. Ceesay	CEO	$400,096	$250,000	—	$1,513,805	$231,167	$20,772	$2,415,840
Troy Ignelzi	CFO	$69,462	—	—	$2,018,084	$35,770	$7,141	$2,130,457

Key facts CIK 2012593 CUSIP 75383L102 13F (30d) 22 filings 22 filers Visit website Investor relations